| Baptist Health Nursing And Rehabilitation Center | |
| 297 N Ballston Ave, Scotia, New York 12302 | |
| (518) 370-4700 | |
| Name | Baptist Health Nursing And Rehabilitation Center |
|---|---|
| Location | 297 N Ballston Ave, Scotia, New York |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 262 |
| Occupancy Rate | 76.6% |
| Medicare ID (CCN) | 335612 |
| Legal Business Name | Baptist Health Nursing & Rehabilitation Center Inc |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1689662157 |
| Organization Name | BAPTIST HEALTH NURSING AND REHABILITATION CENTER INC |
| Address | 297 N Ballston Ave, Scotia, NY 12302 |
| Phone Number | 518-370-4700 |
News Archive
Researchers are warning that women in the last trimester of pregnancy may reduce their risk of stillbirth by falling asleep on their sides rather than their backs.
Steven Poelzing, an associate professor at the Virginia Tech Carilion Research Institute, has received a $2.1 million grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health for research to combat the nation's No. 1 killer — heart disease.
Genervon Biopharmaceuticals announced today that the U.S. Food and Drug Administration has granted an "orphan drug" designation to Genervon's GM604 (a.k.a. GM6) bio-drug for the treatment of Amyotrophic Lateral Sclerosis (ALS). The FDA also granted GM604 a "fast-track" designation for ALS in 2013.
Termed "preimplantation genetic screening (PGS)" the process involves a full chromosome count of embryos to ensure only the healthiest are implanted. It has a 99 per cent accuracy rate, giving hopeful parents the best chance to conceive and carry a healthy baby to term.
Scil Proteins, a private biotech company specialized in the research, development and production of recombinant proteins, announced today that it has signed a supply agreement with Actavis, one of the world's leading generic pharmaceutical companies, for the future manufacturing of Reteplase.
› Verified 5 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Researchers are warning that women in the last trimester of pregnancy may reduce their risk of stillbirth by falling asleep on their sides rather than their backs.
Steven Poelzing, an associate professor at the Virginia Tech Carilion Research Institute, has received a $2.1 million grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health for research to combat the nation's No. 1 killer — heart disease.
Genervon Biopharmaceuticals announced today that the U.S. Food and Drug Administration has granted an "orphan drug" designation to Genervon's GM604 (a.k.a. GM6) bio-drug for the treatment of Amyotrophic Lateral Sclerosis (ALS). The FDA also granted GM604 a "fast-track" designation for ALS in 2013.
Termed "preimplantation genetic screening (PGS)" the process involves a full chromosome count of embryos to ensure only the healthiest are implanted. It has a 99 per cent accuracy rate, giving hopeful parents the best chance to conceive and carry a healthy baby to term.
Scil Proteins, a private biotech company specialized in the research, development and production of recombinant proteins, announced today that it has signed a supply agreement with Actavis, one of the world's leading generic pharmaceutical companies, for the future manufacturing of Reteplase.
› Verified 5 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $650 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 18.54 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 7.01 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 54.14 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.31 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 2.42 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 3.66 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 8 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 96 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 13.54 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 90.07 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0.77 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 28.1 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 18.31 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 11.15 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.52 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 75.62 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 95.77 | 82.93 |
News Archive
Researchers are warning that women in the last trimester of pregnancy may reduce their risk of stillbirth by falling asleep on their sides rather than their backs.
Steven Poelzing, an associate professor at the Virginia Tech Carilion Research Institute, has received a $2.1 million grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health for research to combat the nation's No. 1 killer — heart disease.
Genervon Biopharmaceuticals announced today that the U.S. Food and Drug Administration has granted an "orphan drug" designation to Genervon's GM604 (a.k.a. GM6) bio-drug for the treatment of Amyotrophic Lateral Sclerosis (ALS). The FDA also granted GM604 a "fast-track" designation for ALS in 2013.
Termed "preimplantation genetic screening (PGS)" the process involves a full chromosome count of embryos to ensure only the healthiest are implanted. It has a 99 per cent accuracy rate, giving hopeful parents the best chance to conceive and carry a healthy baby to term.
Scil Proteins, a private biotech company specialized in the research, development and production of recombinant proteins, announced today that it has signed a supply agreement with Actavis, one of the world's leading generic pharmaceutical companies, for the future manufacturing of Reteplase.
› Verified 5 days ago
Glendale Home-schdy Cnty Dept Social Services Location: 59 Hetcheltown Road, Scotia, New York 12302 Phone: (518) 384-3600 | |
Baptist Health Nursing And Rehabilitation Center Location: 297 N Ballston Ave, Scotia, New York 12302 Phone: (518) 370-4700 |